Friess Associates LLC Repligen Corp Transaction History

Friess Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$165.87 - $220.95 $101,346 - $135,000	-611 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $23.2 Million - $29.1 Million	-128,819 Reduced 99.53%	611 $119,000
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $1.26 Million - $1.76 Million	8,524 Added 7.05%	129,430 $24.8 Million
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $14.8 Million - $19.1 Million	120,906 New	120,906 $17.8 Million

482

56.3M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.04B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.